A Breakthrough in Battling Non-Alcoholic Fatty Liver Disease: The Vital Role of B Vitamins
Source: Journal of Hepatology (July 2022)
Lifestyle Medicine Update (August 11, 2022)
Introduction:
Non-Alcoholic Fatty Liver Disease (NAFLD) has quietly become a global health crisis, affecting a staggering 25% of the world’s population. Contrary to its name, NAFLD isn’t solely linked to alcohol consumption. A more sinister variant, Non-Alcoholic Steatohepatitis (NASH), poses a severe threat. Recent research highlights that lifestyle choices, including high-fat diets and sedentary routines, are key contributors to this burgeoning problem. However, a groundbreaking study published in July 2022 offers new hope, unveiling the potential of B vitamins, particularly Vitamin B12 and Folic acid, in combating NASH and safeguarding liver health.
The Global NASH Epidemic: Beyond Alcohol
NASH is no minor concern; it can progress to liver dysfunction, cirrhosis, and even elevate the risk of primary liver cancer. The surge in NASH cases is closely linked to global lifestyle trends, such as rising obesity rates, increased consumption of fatty and sugary foods, and a decline in physical activity. It’s time to recognize that the path to protecting your liver health is more than just about avoiding alcohol.
The Role of Diet and Exercise
An effective strategy for preventing and reversing early-stage NASH involves dietary changes and increased physical activity. Reducing the intake of high-fat animal products and fried foods can serve as a crucial step. Similarly, managing sugar consumption and embracing regular endurance exercises can be equally impactful.
The Link Between Homocysteine and NASH
In a significant breakthrough, researchers discovered that individuals with progressive NASH often exhibit high blood levels of homocysteine. This compound is linked to the damage of enzymes and structures within liver cells, accelerating NASH’s progression towards serious liver dysfunction and cirrhosis.
B Vitamins: A Game-Changer
The research, published in the *Journal of Hepatology*, demonstrated that Vitamin B12 and Folic acid supplements can effectively lower homocysteine levels. This reduction results in a remarkable improvement in liver function. Vitamin B12 and Folic acid help recycle homocysteine back to methionine within our cells, including liver cells. By doing so, they lower homocysteine levels, restoring normal liver cell function. These findings propose Vitamin B12 and Folic acid supplementation as a promising first-line therapy for NASH, particularly for individuals with high homocysteine blood levels.
Prioritize Liver Health
To ensure your liver’s well-being, consider an annual check-up of your liver enzymes as part of your standard blood profile. Early-stage NASH is asymptomatic, but elevated liver enzymes can serve as a warning sign. For a comprehensive evaluation, a blood homocysteine test should be included in your follow-up. Elevated homocysteine levels are associated with an increased risk of heart attacks, strokes, Alzheimer’s disease, and can worsen certain mental health conditions. Vitamin B12 and Folic acid can often normalize homocysteine levels if initially found to be elevated.
Conclusion:
In the face of the NASH epidemic, the significance of diet, exercise, and the potential of B vitamins cannot be underestimated. By embracing a proactive approach and adopting a healthy lifestyle, we can safeguard our liver health, mitigating the risk of NASH and its grave consequences.
References:
- [Journal of Hepatology: “Vitamin B12 and folate decrease inflammation and fibrosis in NASH by preventing syntaxin 17 homocyteinylation.” July 8, 2022](https://www.journal-of-hepatology.eu/article/S0168-8278(22)02932-4/fulltext)
- [Science Daily: “B vitamins can potentially be used to treat advanced non-alcoholic fatty liver disease.” August 5, 2022](https://www.journal-of-hepatology.eu/article/S0168-8278(22)02932-4/fulltext)
- [Peng H et al. “Elevated homocysteine levels and risk of cardiovascular and all-cause-mortality: a meta-analysis of prospective studies.” J Zhejiang Univ Sci B. 2015; 16(1)](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288948/)
Dr. Meschino
Dr. James Meschino
ABOUT THE AUTHOR
Dr. James Meschino, DC, MS, ROHP, is an educator, author, and researcher having lectured to thousands of healthcare professionals across North America. He holds a Master’s Degree in Science with specialties in human nutrition and biology and is recognized as an expert in the field of nutrition, anti-aging, fitness, and wellness as well as the author of numerous books.